Korro Bio, Inc. SEC filings KRRO

Korro Bio, Inc. has 830 filings in SEC EDGAR's recent list, going back to Apr 14, 2017. Its latest annual report, Form ARS, was filed on Apr 16, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (agreement ended, results of operations). The company's fiscal year ends on December 31.

Korro Bio, Inc. SEC filings
Form Description Filed Period
10-Q Quarterly report Nov 5, 2026 Sep 30, 2026
8-K Current report
Agreement ended, Results of operations
Nov 5, 2026 Nov 3, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Oct 27, 2026 —
4 Insider transaction Oct 26, 2026 Oct 22, 2026
8-K Current report
Other events
Oct 22, 2026 Oct 22, 2026
8-K Current report
Other events
Oct 5, 2026 Oct 5, 2026
4 Insider transaction Sep 15, 2026 Sep 11, 2026
144 Notice of proposed sale Sep 14, 2026 —
144 Notice of proposed sale Sep 14, 2026 —
4 Insider transaction Sep 14, 2026 Sep 11, 2026
144 Notice of proposed sale Sep 11, 2026 —
144 Notice of proposed sale Sep 11, 2026 —
144 Notice of proposed sale Sep 11, 2026 —
4 Insider transaction Sep 10, 2026 Sep 8, 2026
144 Notice of proposed sale Sep 9, 2026 —
144 Notice of proposed sale Sep 8, 2026 —
4 Insider transaction Aug 28, 2026 Aug 26, 2026
144 Notice of proposed sale Aug 26, 2026 —
144 Notice of proposed sale Aug 26, 2026 —
4 Insider transaction Aug 21, 2026 Aug 19, 2026
144 Notice of proposed sale Aug 19, 2026 —
144 Notice of proposed sale Aug 19, 2026 —
8-K Current report
Other events
Aug 19, 2026 Aug 19, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 14, 2026 —
4 Insider transaction Aug 13, 2026 Aug 11, 2026
4 Insider transaction Aug 13, 2026 Aug 6, 2026
144 Notice of proposed sale Aug 11, 2026 —
144 Notice of proposed sale Aug 11, 2026 —
10-Q Quarterly report Aug 6, 2026 Jun 30, 2026
8-K Current report
Material agreement, Results of operations, Unregistered share sale
Aug 6, 2026 Aug 5, 2026
4 Insider transaction Aug 5, 2026 Aug 4, 2026
SCHEDULE 13D/A Amended ownership over 5% (active) Aug 4, 2026 —
144 Notice of proposed sale Aug 4, 2026 —
SCHEDULE 13G Ownership over 5% (passive) Jul 29, 2026 —
4 Insider transaction Jul 17, 2026 Jul 15, 2026
4 Insider transaction Jul 17, 2026 Jul 15, 2026
4 Insider transaction Jul 17, 2026 Jul 15, 2026
4 Insider transaction Jul 17, 2026 Jul 15, 2026
4 Insider transaction Jul 7, 2026 Jul 2, 2026
144 Notice of proposed sale Jul 6, 2026 —
144 Notice of proposed sale Jul 6, 2026 —
144 Notice of proposed sale Jul 2, 2026 —
144 Notice of proposed sale Jul 2, 2026 —
4 Insider transaction Jun 24, 2026 Jun 22, 2026
144 Notice of proposed sale Jun 24, 2026 —
144 Notice of proposed sale Jun 24, 2026 —
144 Notice of proposed sale Jun 23, 2026 —
144 Notice of proposed sale Jun 23, 2026 —
144 Notice of proposed sale Jun 22, 2026 —
144 Notice of proposed sale Jun 22, 2026 —
4 Insider transaction Jun 17, 2026 Jun 16, 2026
4 Insider transaction Jun 17, 2026 Jun 16, 2026
4 Insider transaction Jun 17, 2026 Jun 16, 2026
4 Insider transaction Jun 17, 2026 Jun 16, 2026
144 Notice of proposed sale Jun 16, 2026 —
144 Notice of proposed sale Jun 16, 2026 —
144 Notice of proposed sale Jun 16, 2026 —
144 Notice of proposed sale Jun 16, 2026 —
4 Insider transaction Jun 11, 2026 Jun 10, 2026
4 Insider transaction Jun 11, 2026 Jun 10, 2026
4 Insider transaction Jun 11, 2026 Jun 10, 2026
4 Insider transaction Jun 11, 2026 Jun 10, 2026
4 Insider transaction Jun 11, 2026 Jun 10, 2026
4 Insider transaction Jun 11, 2026 Jun 10, 2026
8-K Current report
Shareholder vote results
Jun 11, 2026 Jun 10, 2026
4 Insider transaction Jun 2, 2026 May 29, 2026
4 Insider transaction Jun 1, 2026 May 28, 2026
144 Notice of proposed sale May 29, 2026 —
4 Insider transaction May 28, 2026 May 26, 2026
8-K Current report
Other events
May 19, 2026 May 19, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) May 15, 2026 —
424B3 Prospectus May 12, 2026 —
10-Q Quarterly report May 7, 2026 Mar 31, 2026
8-K Current report
Results of operations
May 7, 2026 May 7, 2026
ARS Annual report to shareholders Apr 16, 2026 Dec 31, 2025
DEFA14A Additional proxy material Apr 16, 2026 —
DEF 14A Proxy statement Apr 16, 2026 Jun 10, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Apr 2, 2026 —
4 Insider transaction Apr 2, 2026 Mar 31, 2026
3 Initial insider ownership Apr 2, 2026 Mar 31, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Mar 27, 2026 —
EFFECT Filing Mar 20, 2026 —
424B5 Prospectus supplement Mar 20, 2026 —
CORRESP Letter to the SEC Mar 18, 2026 —
UPLOAD Letter from the SEC Mar 18, 2026 —
SCHEDULE 13G Ownership over 5% (passive) Mar 17, 2026 —
S-3 Shelf registration Mar 13, 2026 —
4 Insider transaction Mar 12, 2026 Mar 10, 2026
4 Insider transaction Mar 12, 2026 Mar 10, 2026
4 Insider transaction Mar 12, 2026 Mar 10, 2026
4 Insider transaction Mar 12, 2026 Mar 10, 2026
4 Insider transaction Mar 12, 2026 Mar 10, 2026
4 Insider transaction Mar 12, 2026 Mar 10, 2026
4 Insider transaction Mar 12, 2026 Mar 10, 2026
4 Insider transaction Mar 12, 2026 Mar 10, 2026
4 Insider transaction Mar 12, 2026 Mar 10, 2026
4 Insider transaction Mar 12, 2026 Mar 10, 2026
SCHEDULE 13D/A Amended ownership over 5% (active) Mar 12, 2026 —
10-K Annual report Mar 12, 2026 Dec 31, 2025
8-K Current report
Results of operations
Mar 12, 2026 Mar 12, 2026
SCHEDULE 13G Ownership over 5% (passive) Mar 11, 2026 —
8-K Current report
Material agreement, Results of operations, Unregistered share sale, Regulation FD disclosure
Mar 9, 2026 Mar 9, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 17, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 17, 2026 —
SCHEDULE 13G Ownership over 5% (passive) Feb 13, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 5, 2026 —
4 Insider transaction Feb 3, 2026 Feb 2, 2026
4 Insider transaction Feb 3, 2026 Feb 2, 2026
4 Insider transaction Feb 3, 2026 Feb 2, 2026
4 Insider transaction Feb 3, 2026 Feb 2, 2026
4 Insider transaction Feb 3, 2026 Feb 2, 2026
SCHEDULE 13G Ownership over 5% (passive) Jan 30, 2026 —
S-8 Employee stock plan registration Jan 27, 2026 —
8-K Current report
Other events
Jan 27, 2026 Jan 27, 2026
8-K Current report
Other events
Jan 15, 2026 Jan 15, 2026
SCHEDULE 13G Ownership over 5% (passive) Jan 5, 2026 —
8-K Current report
Officer or director change
Dec 18, 2025 Dec 15, 2025
4 Insider transaction Dec 16, 2025 Dec 15, 2025
4 Insider transaction Dec 16, 2025 Dec 15, 2025
4 Insider transaction Dec 16, 2025 Dec 15, 2025
4 Insider transaction Dec 16, 2025 Dec 15, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Nov 14, 2025 —
10-Q Quarterly report Nov 12, 2025 Sep 30, 2025
8-K Current report
Material agreement, Results of operations, Exit or restructuring costs, Officer or director change
Nov 12, 2025 Nov 7, 2025
8-K Current report
Officer or director change
Oct 8, 2025 Oct 7, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 14, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 14, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 13, 2025 —
10-Q Quarterly report Aug 12, 2025 Jun 30, 2025
8-K Current report
Results of operations
Aug 12, 2025 Aug 12, 2025
8-K/A Amended current report
Shareholder vote results
Jun 18, 2025 Jun 11, 2025
4 Insider transaction Jun 12, 2025 Jun 11, 2025
4 Insider transaction Jun 12, 2025 Jun 11, 2025
4 Insider transaction Jun 12, 2025 Jun 11, 2025
4 Insider transaction Jun 12, 2025 Jun 11, 2025
4 Insider transaction Jun 12, 2025 Jun 11, 2025
4 Insider transaction Jun 12, 2025 Jun 11, 2025
8-K Current report
Shareholder vote results
Jun 11, 2025 Jun 11, 2025
10-Q Quarterly report May 7, 2025 Mar 31, 2025
8-K Current report
Results of operations, Exit or restructuring costs
May 7, 2025 May 7, 2025
ARS Annual report to shareholders Apr 29, 2025 Dec 31, 2024
DEFA14A Additional proxy material Apr 29, 2025 —
DEF 14A Proxy statement Apr 29, 2025 Jun 11, 2025
4 Insider transaction Apr 1, 2025 Apr 1, 2025
4 Insider transaction Apr 1, 2025 Apr 1, 2025
3 Initial insider ownership Apr 1, 2025 Mar 31, 2025
8-K Current report
Officer or director change
Mar 27, 2025 Mar 27, 2025
S-8 Employee stock plan registration Mar 18, 2025 —
10-K Annual report Mar 18, 2025 Dec 31, 2024
8-K Current report
Results of operations
Mar 18, 2025 Mar 18, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 14, 2025 —
SCHEDULE 13G Ownership over 5% (passive) Feb 14, 2025 —
3 Initial insider ownership Feb 11, 2025 Feb 11, 2025
8-K Current report
Officer or director change
Feb 11, 2025 Feb 11, 2025
4 Insider transaction Feb 5, 2025 Feb 3, 2025
SCHEDULE 13G Ownership over 5% (passive) Feb 5, 2025 —
4 Insider transaction Feb 5, 2025 Feb 3, 2025
4 Insider transaction Feb 5, 2025 Feb 3, 2025
4 Insider transaction Feb 5, 2025 Feb 3, 2025
4 Insider transaction Feb 5, 2025 Feb 3, 2025
8-K Current report
Other events
Jan 13, 2025 Jan 13, 2025
424B3 Prospectus Dec 10, 2024 —
424B3 Prospectus Dec 10, 2024 —
EFFECT Filing Dec 9, 2024 —
EFFECT Filing Dec 9, 2024 —
EFFECT Filing Dec 6, 2024 —
424B5 Prospectus supplement Dec 6, 2024 —
CORRESP Letter to the SEC Dec 6, 2024 —
UPLOAD Letter from the SEC Dec 6, 2024 —
POS AM Filing Dec 2, 2024 —
POS AM Filing Dec 2, 2024 —
S-3 Shelf registration Dec 2, 2024 —
424B3 Prospectus Nov 21, 2024 —
424B3 Prospectus Nov 21, 2024 —
8-K Current report
Other events
Nov 21, 2024 Nov 21, 2024
SC 13G/A Amended ownership over 5% (passive) Nov 14, 2024 —
SC 13G/A Amended ownership over 5% (passive) Nov 14, 2024 —
SC 13G/A Amended ownership over 5% (passive) Nov 14, 2024 —
SC 13G/A Amended ownership over 5% (passive) Nov 14, 2024 —
4 Insider transaction Nov 12, 2024 Nov 11, 2024
424B3 Prospectus Nov 12, 2024 —
424B3 Prospectus Nov 12, 2024 —
10-Q Quarterly report Nov 12, 2024 Sep 30, 2024
8-K Current report
Results of operations
Nov 12, 2024 Nov 12, 2024
SC 13G/A Amended ownership over 5% (passive) Nov 12, 2024 —
144 Notice of proposed sale Nov 12, 2024 —
424B3 Prospectus Nov 4, 2024 —
424B3 Prospectus Nov 4, 2024 —
8-K Current report
Other events
Nov 4, 2024 Nov 4, 2024
4 Insider transaction Oct 18, 2024 Oct 17, 2024
144 Notice of proposed sale Oct 17, 2024 —
144 Notice of proposed sale Oct 16, 2024 —
424B3 Prospectus Sep 16, 2024 —
424B3 Prospectus Sep 16, 2024 —
8-K Current report
Material agreement
Sep 16, 2024 Sep 13, 2024
4 Insider transaction Sep 3, 2024 Sep 3, 2024
3 Initial insider ownership Sep 3, 2024 Aug 30, 2024
144 Notice of proposed sale Aug 30, 2024 —
4 Insider transaction Aug 28, 2024 Aug 26, 2024
3 Initial insider ownership Aug 28, 2024 Aug 26, 2024

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
KRRO (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Cambridge, MA
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1703647
Former names
Frequency Therapeutics, Inc. (until Nov 6, 2023)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.